Clinical Trial Update: Withdrawal of Treatment for Heart Failure Patients With Recovery From Tachycardia-induced Cardiomyopathy [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update regarding withdrawing treatment in heart failure patients who have recovered from tachycardia-induced cardiomyopathy in Phase 2 and Phas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Arrhythmia
• Heart Failure with Reduced Ejection Fraction
• Tachycardia-induced Cardiomyopathy

Snippet

Sponsor: Herlev and Gentofte Hospital | Conditions: Heart Failure With Reduced Ejection Fraction, Heart Rhythm Disorder | Phase 2, Phase 3 | Status: RECRUITING